Pay in 4 interest-free payments of $6.44 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
PMID: 40005999 | doi:10.3390/ph18020185 McGuire FP et al
Research has also examined the compounds stability and formulation requirements
Quality control issues present practical safety concerns beyond inherent peptide properties
Unlike most peptides used in research, BPC-157 is stable in gastric acid, which is unusual for a peptide and relevant to its oral bioavailability in animal models (Sikiric et al., 2018)
The benefits often prove particularly valuable for older adults dealing with accumulated injuries and slower natural healing
human bioavailability is unknown Subcutaneous injection Human subcutaneous bioavailability and pharmacokinetics are unknown Factor Convenience Oral capsules No mixing or syringe math Subcutaneous injection Requires reconstitution, sterile supplies, and injection-site planning Factor Evidence limits Oral capsules No controlled human dose, benefit, or safety trial Subcutaneous injection No controlled human dose, benefit, or safety trial Factor Can the amounts be treated as equal
US$ 28.37
US$ 24.67
US$ 23.83
US$ 23.61
US$ 20.04
